Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients. (Q48255185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Claudio Bellevicine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Elena Vigliar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

Roberta Sgariglia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

Pierlorenzo Pallante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Lorenzo Colarossi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Domenico Vitale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giancarlo Troncone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

5 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pathology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

64-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25378536%20AND%20SRC:MED&resulttype=core&format=json

KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Next-generation sequencing: a change of paradigm in molecular diagnostic validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

An integrated semiconductor device enabling non-optical genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Genomic and biological characterization of exon 4 KRAS mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691

Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202691